Treatment of animals with excessive -amyloidosis with newly developed reversible MAO-B inhibitor KDS2010 or the potent H 2 O 2 scavenger AAD-2004 ameliorated neurodegeneration
It falls far short of the appropriate design for a clinical trial safety test that might use 3 pulses of 0.5 mg each to test safety in humans before proceeding with incremental higher doses
Some triggers develop slowly over time, while others appear after injury or medication use
Do , bng cch thc y sn xut creatine, betaine c th gin tip ci thin sc mnh v sc bn ca bn, c bit trong nhng bi tp cng cao, nhanh v mnh nh nng t
AMA Biological aging tests, longevity training, emerging therapies, GLP-1 RAs, sun exposure, and more #383 AMA #81: Biological aging tests, longevity training, emerging therapies, GLP-1 RAs, sun exposure, and more In this Ask Me Anything (AMA) episode, Peter answers listener questions that pull back the curtain on how he actually thinks and operates across a wide range of topics in health and longevity